Skip to main content
Erschienen in: Wiener Medizinische Wochenschrift 21-22/2012

01.11.2012 | main topic

Usage and limitations of liquid chromatography-tandem mass spectrometry (LC–MS/MS) in clinical routine laboratories

verfasst von: Christoph Seger

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 21-22/2012

Einloggen, um Zugang zu erhalten

Summary

Technical maturation of liquid chromato-graphy tandem mass spectrometry (LC–MS/MS) brought this technology into most tertiary care clinical laboratories worldwide. It extended the technological armamentarium of clinical laboratories significantly, both in analytical and economical terms. Especially in therapeutic drug monitoring, endocrinology, and toxicology, it became an indispensable routine tool. Although well-designed LC–MS/MS assays generally outperform immunoassays because of increased accuracy, sensitivity, precision, and analytical multiplexing capability, they are not free from analytical problems. Besides limitations in selectivity due to the occurrence of “isobaric” interferences, unpredictable ion yield attenuations, known as “ion suppression effect,” have to be considered. In addition, most LC–MS/MS methods used in clinical laboratories are still laboratory-developed tests (“in-house assays”) operating on very heterogeneous instrument configurations. Consequently, assay heterogeneity and lack of traceability to reference procedures or materials may lead to an increased imprecision in proficiency testing as well as inaccurate result reporting if basic rules of assay validation and “post marketing” surveillance are violated.
Literatur
1.
Zurück zum Zitat Müller MM. Implementation of reference systems in laboratory medicine. Clin Chem. 2000;46:1907–9.PubMed Müller MM. Implementation of reference systems in laboratory medicine. Clin Chem. 2000;46:1907–9.PubMed
2.
Zurück zum Zitat Panteghini M. Traceability as a unique tool to improve standardization in laboratory medicine. Clin Biochem. 2009;42:236–40.PubMedCrossRef Panteghini M. Traceability as a unique tool to improve standardization in laboratory medicine. Clin Biochem. 2009;42:236–40.PubMedCrossRef
3.
Zurück zum Zitat Yalow RS. Radioimmunoassay: a probe for the fine structure of biologic systems. Science. 1978;200:1236–45.PubMedCrossRef Yalow RS. Radioimmunoassay: a probe for the fine structure of biologic systems. Science. 1978;200:1236–45.PubMedCrossRef
4.
Zurück zum Zitat Winter WE, Sokoll LJ, Jialal I, editors. Handbook of diagnostic endocrinology. Washington DC: AACC; 2008. Winter WE, Sokoll LJ, Jialal I, editors. Handbook of diagnostic endocrinology. Washington DC: AACC; 2008.
5.
Zurück zum Zitat Fenn JB. Electrospray wings for molecular elephants (Nobel lecture). Angew Chem Int Ed Engl. 2003;42:3871–94.PubMedCrossRef Fenn JB. Electrospray wings for molecular elephants (Nobel lecture). Angew Chem Int Ed Engl. 2003;42:3871–94.PubMedCrossRef
6.
Zurück zum Zitat Himmelsbach M. 10 years of MS instrumental developments—impact on LC-MS/MS in clinical chemistry. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;883–4:3–17. Himmelsbach M. 10 years of MS instrumental developments—impact on LC-MS/MS in clinical chemistry. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;883–4:3–17.
7.
Zurück zum Zitat Chace DH. Mass spectrometry in newborn and metabolic screening: historical perspective and future directions. J Mass Spectrom. 2009;44:163–70.PubMedCrossRef Chace DH. Mass spectrometry in newborn and metabolic screening: historical perspective and future directions. J Mass Spectrom. 2009;44:163–70.PubMedCrossRef
8.
Zurück zum Zitat Seger C, Vogeser M. Immunosuppressant drug monitoring—a routine undertaking? J Lab Med. 2010;34:117–28. Seger C, Vogeser M. Immunosuppressant drug monitoring—a routine undertaking? J Lab Med. 2010;34:117–28.
9.
Zurück zum Zitat Vogeser M, Seger C. Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory. Clin Chem. 2010;56:1234–44.PubMedCrossRef Vogeser M, Seger C. Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory. Clin Chem. 2010;56:1234–44.PubMedCrossRef
10.
Zurück zum Zitat Picard S, Titier K, Etienne G, Teilhet E, Ducint D, Bernard MA, et al. Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia. Blood. 2007;109:3496–9.PubMedCrossRef Picard S, Titier K, Etienne G, Teilhet E, Ducint D, Bernard MA, et al. Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia. Blood. 2007;109:3496–9.PubMedCrossRef
11.
Zurück zum Zitat Adaway JE, Keevil BG. Therapeutic drug monitoring and LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;883–884:33–49.PubMed Adaway JE, Keevil BG. Therapeutic drug monitoring and LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;883–884:33–49.PubMed
12.
Zurück zum Zitat Taylor PJ, Franklin ME, Tai CH, Pillans PI. Therapeutic drug monitoring of tacrolimus by liquid chromatography-tandem mass spectrometry: is it truly a routine test? J Chromatogr B Analyt Technol Biomed Life Sci. 2012;883–884:108–12.PubMed Taylor PJ, Franklin ME, Tai CH, Pillans PI. Therapeutic drug monitoring of tacrolimus by liquid chromatography-tandem mass spectrometry: is it truly a routine test? J Chromatogr B Analyt Technol Biomed Life Sci. 2012;883–884:108–12.PubMed
13.
Zurück zum Zitat Saar E, Beyer J, Gerostamoulos D, Drummer OH. The analysis of antipsychotic drugs in human matrices using LC-MS(/MS). Drug Test Anal. 2012;4:376–94.PubMedCrossRef Saar E, Beyer J, Gerostamoulos D, Drummer OH. The analysis of antipsychotic drugs in human matrices using LC-MS(/MS). Drug Test Anal. 2012;4:376–94.PubMedCrossRef
14.
Zurück zum Zitat Carvalho VM. The coming of age of liquid chromatography coupled to tandem mass spectrometry in the endocrinology laboratory. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;883–884:50–8.PubMed Carvalho VM. The coming of age of liquid chromatography coupled to tandem mass spectrometry in the endocrinology laboratory. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;883–884:50–8.PubMed
15.
Zurück zum Zitat Peters FT. Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology. Clin Biochem. 2011;44:54–65. Peters FT. Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology. Clin Biochem. 2011;44:54–65.
16.
Zurück zum Zitat Maurer HH. Perspectives of liquid chromatography coupled to low- and high-resolution mass spectrometry for screening, identification, and quantification of drugs in clinical and forensic toxicology. Ther Drug Monit. 2010;32:324–7.PubMedCrossRef Maurer HH. Perspectives of liquid chromatography coupled to low- and high-resolution mass spectrometry for screening, identification, and quantification of drugs in clinical and forensic toxicology. Ther Drug Monit. 2010;32:324–7.PubMedCrossRef
17.
Zurück zum Zitat Wissenbach DK, Meyer MR, Weber AA, Remane D, Ewald AH, Peters FT, et al. Towards a universal LC-MS screening procedure—can an LIT LC-MS(n) screening approach and reference library be used on a quadrupole-LIT hybrid instrument? J Mass Spectrom. 2012;47:66–71.PubMedCrossRef Wissenbach DK, Meyer MR, Weber AA, Remane D, Ewald AH, Peters FT, et al. Towards a universal LC-MS screening procedure—can an LIT LC-MS(n) screening approach and reference library be used on a quadrupole-LIT hybrid instrument? J Mass Spectrom. 2012;47:66–71.PubMedCrossRef
18.
Zurück zum Zitat Dresen S, Ferreirós N, Gnann H, Zimmermann R, Weinmann W. Detection and identification of 700 drugs by multi-target screening with a 3200 Q TRAP LC-MS/MS system and library searching. Anal Bioanal Chem. 2010;396:2425–34.PubMedCrossRef Dresen S, Ferreirós N, Gnann H, Zimmermann R, Weinmann W. Detection and identification of 700 drugs by multi-target screening with a 3200 Q TRAP LC-MS/MS system and library searching. Anal Bioanal Chem. 2010;396:2425–34.PubMedCrossRef
19.
Zurück zum Zitat Oberacher H, Pitterl F, Siapi E, Steele BR, Letzel T, Grosse S, et al. On the inter-instrument and the inter-laboratory transferability of a tandem mass spectral reference library. 3. Focus on ion trap and upfront CID. J Mass Spectrom. 2012;47:263–70.PubMedCrossRef Oberacher H, Pitterl F, Siapi E, Steele BR, Letzel T, Grosse S, et al. On the inter-instrument and the inter-laboratory transferability of a tandem mass spectral reference library. 3. Focus on ion trap and upfront CID. J Mass Spectrom. 2012;47:263–70.PubMedCrossRef
20.
Zurück zum Zitat Oberacher H, Weinmann W, Dresen S. Quality evaluation of tandem mass spectral libraries. Anal Bioanal Chem. 2011;400:2641–8.PubMedCrossRef Oberacher H, Weinmann W, Dresen S. Quality evaluation of tandem mass spectral libraries. Anal Bioanal Chem. 2011;400:2641–8.PubMedCrossRef
21.
22.
Zurück zum Zitat Yates AM, Bowron A, Calton L, Heynes J, Field H, Rainbow S, et al. Interlaboratory variation in 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 is significantly improved if common calibration material is used. Clin Chem. 2008;54:2082–4.PubMedCrossRef Yates AM, Bowron A, Calton L, Heynes J, Field H, Rainbow S, et al. Interlaboratory variation in 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 is significantly improved if common calibration material is used. Clin Chem. 2008;54:2082–4.PubMedCrossRef
23.
Zurück zum Zitat Carter GD, Jones JC. Use of a common standard improves the performance of liquid chromatography-tandem mass spectrometry methods for serum 25-hydroxyvitamin-D. Ann Clin Biochem. 2009;46:79–81.PubMedCrossRef Carter GD, Jones JC. Use of a common standard improves the performance of liquid chromatography-tandem mass spectrometry methods for serum 25-hydroxyvitamin-D. Ann Clin Biochem. 2009;46:79–81.PubMedCrossRef
24.
Zurück zum Zitat Phinney KW, Bedner M, Tai SS, Vamathevan VV, Sander LC, Sharpless KE, et al. Development and certification of a standard reference material for vitamin D metabolites in human serum. Anal Chem. 2012;84:956–62.PubMedCrossRef Phinney KW, Bedner M, Tai SS, Vamathevan VV, Sander LC, Sharpless KE, et al. Development and certification of a standard reference material for vitamin D metabolites in human serum. Anal Chem. 2012;84:956–62.PubMedCrossRef
25.
Zurück zum Zitat Schleicher RL, Encisco SE, Chaudhary-Webb M, Paliakov E, McCoy LF, Pfeiffer CM. Isotope dilution ultra performance liquid chromatography-tandem mass spectrometry method for simultaneous measurement of 25-hydroxyvitamin D2, 25-hydroxyvitamin D3 and 3-epi-25-hydroxyvitamin D3 in human serum. Clin Chim Acta. 2011;412:1594–9.PubMedCrossRef Schleicher RL, Encisco SE, Chaudhary-Webb M, Paliakov E, McCoy LF, Pfeiffer CM. Isotope dilution ultra performance liquid chromatography-tandem mass spectrometry method for simultaneous measurement of 25-hydroxyvitamin D2, 25-hydroxyvitamin D3 and 3-epi-25-hydroxyvitamin D3 in human serum. Clin Chim Acta. 2011;412:1594–9.PubMedCrossRef
26.
Zurück zum Zitat Stepman HC, Vanderroost A, Van Uytfanghe K, Thienpont LM. Candidate reference measurement procedures for serum 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 by using isotope-dilution liquid chromatography-tandem mass spectrometry. Clin Chem. 2011;57:441–8.PubMedCrossRef Stepman HC, Vanderroost A, Van Uytfanghe K, Thienpont LM. Candidate reference measurement procedures for serum 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 by using isotope-dilution liquid chromatography-tandem mass spectrometry. Clin Chem. 2011;57:441–8.PubMedCrossRef
27.
Zurück zum Zitat Seger C, Tentschert K, Stöggl W, Griesmacher A, Ramsay SL. A rapid HPLC-MS/MS method for the simultaneous quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human blood samples. Nat Protoc. 2009;4:526–34.PubMedCrossRef Seger C, Tentschert K, Stöggl W, Griesmacher A, Ramsay SL. A rapid HPLC-MS/MS method for the simultaneous quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human blood samples. Nat Protoc. 2009;4:526–34.PubMedCrossRef
28.
Zurück zum Zitat Vogeser M, Seger C. A decade of HPLC-MS/MS in the routine clinical laboratory—goals for further developments. Clin Biochem. 2008;41:649–62.PubMedCrossRef Vogeser M, Seger C. A decade of HPLC-MS/MS in the routine clinical laboratory—goals for further developments. Clin Biochem. 2008;41:649–62.PubMedCrossRef
29.
Zurück zum Zitat Yuan C, Kosewick J, He X, Kozak M, Wang S. Sensitive measurement of serum 1a,25-dihydroxyvitamin D by liquid chromatography/tandem mass spectrometry after removing interference with immunoaffinity extraction. Rapid Commun Mass Spectrom. 2011;25:1241–9.PubMedCrossRef Yuan C, Kosewick J, He X, Kozak M, Wang S. Sensitive measurement of serum 1a,25-dihydroxyvitamin D by liquid chromatography/tandem mass spectrometry after removing interference with immunoaffinity extraction. Rapid Commun Mass Spectrom. 2011;25:1241–9.PubMedCrossRef
30.
Zurück zum Zitat Strathmann FG, Laha TJ, Hoofnagle AN. Quantification of 1a,25-dihydroxy vitamin D by immunoextraction and liquid chromatography-tandem mass spectrometry. Clin Chem. 2011;57:1279–85.PubMedCrossRef Strathmann FG, Laha TJ, Hoofnagle AN. Quantification of 1a,25-dihydroxy vitamin D by immunoextraction and liquid chromatography-tandem mass spectrometry. Clin Chem. 2011;57:1279–85.PubMedCrossRef
31.
Zurück zum Zitat Casetta B, Jans I, Billen J, Vanderschueren D, Bouillon R. Development of a method for the quantification of 1alpha,25(OH)2-vitamin D3 in serum by liquid chromatography tandem mass spectrometry without derivatization. Eur J Mass Spectrom (Chichester, Eng). 2010;16:81–9.CrossRef Casetta B, Jans I, Billen J, Vanderschueren D, Bouillon R. Development of a method for the quantification of 1alpha,25(OH)2-vitamin D3 in serum by liquid chromatography tandem mass spectrometry without derivatization. Eur J Mass Spectrom (Chichester, Eng). 2010;16:81–9.CrossRef
32.
Zurück zum Zitat Singh RJ, Taylor RL, Reddy GS, Grebe SK. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab. 2006;91:3055–61.PubMedCrossRef Singh RJ, Taylor RL, Reddy GS, Grebe SK. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab. 2006;91:3055–61.PubMedCrossRef
33.
Zurück zum Zitat Molnar F, Sigüeiro R, Sato Y, Araujo C, Schuster I, Antony P, et al. 1a,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor. PLoS One. 2011;6:e18124.PubMedCrossRef Molnar F, Sigüeiro R, Sato Y, Araujo C, Schuster I, Antony P, et al. 1a,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor. PLoS One. 2011;6:e18124.PubMedCrossRef
34.
Zurück zum Zitat Strathmann FG, Sadilkova K, Laha TJ, LeSourd SE, Bornhorst JA, Hoofnagle AN, et al. 3-epi-25 hydroxyvitamin D concentrations are not correlated with age in a cohort of infants and adults. Clin Chim Acta. 2012;413:203–6.PubMedCrossRef Strathmann FG, Sadilkova K, Laha TJ, LeSourd SE, Bornhorst JA, Hoofnagle AN, et al. 3-epi-25 hydroxyvitamin D concentrations are not correlated with age in a cohort of infants and adults. Clin Chim Acta. 2012;413:203–6.PubMedCrossRef
35.
Zurück zum Zitat Stepman HC, Vanderroost A, Stöckl D, Thienpont LM. Full-scan mass spectral evidence for 3-epi-25-hydroxyvitamin D3 in serum of infants and adults. Clin Chem Lab Med. 2011;49:253–6.PubMed Stepman HC, Vanderroost A, Stöckl D, Thienpont LM. Full-scan mass spectral evidence for 3-epi-25-hydroxyvitamin D3 in serum of infants and adults. Clin Chem Lab Med. 2011;49:253–6.PubMed
36.
Zurück zum Zitat Lensmeyer G, Poquette M, Wiebe D, Binkley N. The C-3 epimer of 25-hydroxyvitamin D(3) is present in adult serum. J Clin Endocrinol Metab. 2012;97:163–8.PubMedCrossRef Lensmeyer G, Poquette M, Wiebe D, Binkley N. The C-3 epimer of 25-hydroxyvitamin D(3) is present in adult serum. J Clin Endocrinol Metab. 2012;97:163–8.PubMedCrossRef
37.
Zurück zum Zitat Keevil B. Does the presence of 3-epi-25OHD3 affect the routine measurement of vitamin D using liquid chromatography tandem mass spectrometry? Clin Chem Lab Med. 2011;50:181–3.PubMed Keevil B. Does the presence of 3-epi-25OHD3 affect the routine measurement of vitamin D using liquid chromatography tandem mass spectrometry? Clin Chem Lab Med. 2011;50:181–3.PubMed
38.
Zurück zum Zitat Vogeser M, Zachoval R, Spöhrer U, Jacob K. Potential lack of specificity using electrospray tandem-mass spectrometry for the analysis of mycophenolic acid in serum. Ther Drug Monit. 2001;23:722–4.PubMedCrossRef Vogeser M, Zachoval R, Spöhrer U, Jacob K. Potential lack of specificity using electrospray tandem-mass spectrometry for the analysis of mycophenolic acid in serum. Ther Drug Monit. 2001;23:722–4.PubMedCrossRef
39.
Zurück zum Zitat Vogeser M, Spöhrer U. Pitfall in the high-throughput quantification of whole blood cyclosporin A using liquid chromatography-tandem mass spectrometry. Clin Chem Lab Med. 2005;43:400–2.PubMed Vogeser M, Spöhrer U. Pitfall in the high-throughput quantification of whole blood cyclosporin A using liquid chromatography-tandem mass spectrometry. Clin Chem Lab Med. 2005;43:400–2.PubMed
40.
Zurück zum Zitat Rauh M. LC-MS/MS for protein and peptide quantification in clinical chemistry. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;883–884:59–67.PubMed Rauh M. LC-MS/MS for protein and peptide quantification in clinical chemistry. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;883–884:59–67.PubMed
41.
Zurück zum Zitat Picotti P, Aebersold R. Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat Methods. 2012;9:555–66.PubMedCrossRef Picotti P, Aebersold R. Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat Methods. 2012;9:555–66.PubMedCrossRef
Metadaten
Titel
Usage and limitations of liquid chromatography-tandem mass spectrometry (LC–MS/MS) in clinical routine laboratories
verfasst von
Christoph Seger
Publikationsdatum
01.11.2012
Verlag
Springer Vienna
Erschienen in
Wiener Medizinische Wochenschrift / Ausgabe 21-22/2012
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI
https://doi.org/10.1007/s10354-012-0147-3

Weitere Artikel der Ausgabe 21-22/2012

Wiener Medizinische Wochenschrift 21-22/2012 Zur Ausgabe

editorial

Biomarkers